Clinical Trials Browser

Not yet recruiting × Glioma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT05366062 2022-05-13

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab

Phase 2 Not yet recruiting

Glioma